Ascidian Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Ascidian Therapeutics is a clinical-stage biotechnology company developing exon-editing RNA therapeutics to target the underlying causes of disease.
June 16-19, 2025
Boston Convention & Exhibition Center
Ascidian Therapeutics is a clinical-stage biotechnology company developing exon-editing RNA therapeutics to target the underlying causes of disease.